LBC
PFE icon

Lowe Brockenbrough & Co’s Pfizer PFE Stock Holding History

Lowe Brockenbrough & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.71M Buy
238,855
+29,130
+14% +$776K 0.33% 72
2025
Q4 		$5.22M Buy
209,725
+3,251
+2% +$82K 0.26% 84
2025
Q3 		$5.26M Buy
206,474
+15,992
+8% +$395K 0.27% 82
2025
Q2 		$4.62M Sell
190,482
-3,779
-2% -$88.1K 0.26% 84
2025
Q1 		$4.92M Buy
194,261
+35,283
+22% +$923K 0.32% 78
2024
Q4 		$4.22M Sell
158,978
-103,314
-39% -$2.8M 0.27% 86
2024
Q3 		$7.59M Sell
262,292
-19,877
-7% -$580K 0.48% 60
2024
Q2 		$7.89M Buy
282,169
+5,525
+2% +$152K 0.53% 60
2024
Q1 		$7.68M Buy
276,644
+21,122
+8% +$586K 0.52% 61
2023
Q4 		$7.36M Sell
255,522
-5,010
-2% -$151K 0.57% 53
2023
Q3 		$8.64M Buy
260,532
+62,956
+32% +$2.23M 0.67% 48
2023
Q2 		$7.25M Buy
197,576
+34,837
+21% +$1.36M 0.55% 59
2023
Q1 		$6.64M Buy
162,739
+2,358
+1% +$102K 0.54% 57
2022
Q4 		$8.22M Buy
160,381
+2,512
+2% +$120K 0.72% 48
2022
Q3 		$6.91M Sell
157,869
-9,176
-5% -$446K 0.67% 50
2022
Q2 		$8.76M Buy
167,045
+2,556
+2% +$130K 0.77% 40
2022
Q1 		$8.52M Sell
164,489
-286
-0.2% -$14.8K 0.63% 53
2021
Q4 		$9.73M Buy
164,775
+345
+0.2% +$17.1K 0.71% 49
2021
Q3 		$7.07M Buy
164,430
+1,425
+0.9% +$63.1K 0.55% 57
2021
Q2 		$6.38M Buy
163,005
+3,445
+2% +$134K 0.57% 58
2021
Q1 		$5.78M Buy
159,560
+2,931
+2% +$104K 0.56% 60
2020
Q4 		$5.76M Sell
156,629
-1,537
-1% -$56.4K 0.62% 57
2020
Q3 		$5.51M Buy
158,166
+2,057
+1% +$72.1K 0.68% 51
2020
Q2 		$4.84M Buy
156,109
+853
+0.5% +$29K 0.65% 52
2020
Q1 		$4.81M Buy
155,256
+2,832
+2% +$96.5K 0.79% 43
2019
Q4 		$5.67M Buy
152,424
+1,808
+1% +$64.4K 0.7% 52
2019
Q3 		$5.13M Buy
150,616
+1,225
+0.8% +$44.5K 0.69% 51
2019
Q2 		$6.14M Sell
149,391
-358
-0.2% -$14.2K 0.84% 40
2019
Q1 		$6.03M Buy
149,749
+11,953
+9% +$479K 0.84% 37
2018
Q4 		$5.71M Buy
137,796
+1,424
+1% +$59.1K 0.93% 37
2018
Q3 		$5.7M Sell
136,372
-1,138
-0.8% -$43.8K 0.8% 43
2018
Q2 		$4.73M Buy
137,510
+5,179
+4% +$177K 0.7% 53
2018
Q1 		$4.46M Buy
132,331
+113,119
+589% +$3.89M 0.66% 52
2017
Q4 		$660K Sell
19,212
-158
-0.8% -$5.39K 0.09% 147
2017
Q3 		$656K Sell
19,370
-2,161
-10% -$69.5K 0.1% 145
2017
Q2 		$686K Sell
21,531
-270
-1% -$8.52K 0.11% 139
2017
Q1 		$708K Buy
21,801
+1,777
+9% +$56K 0.11% 136
2016
Q4 		$617K Sell
20,024
-218
-1% -$6.66K 0.1% 141
2016
Q3 		$650K Buy
20,242
+1,792
+10% +$59.9K 0.11% 138
2016
Q2 		$616K Sell
18,450
-316
-2% -$10.1K 0.11% 140
2016
Q1 		$528K Sell
18,766
-337
-2% -$9.63K 0.09% 153
2015
Q4 		$585K Sell
19,103
-52
-0.3% -$1.64K 0.1% 149
2015
Q3 		$571K Sell
19,155
-264
-1% -$8.46K 0.1% 152
2015
Q2 		$618K Sell
19,419
-211
-1% -$6.88K 0.1% 154
2015
Q1 		$648K Sell
19,630
-1,047
-5% -$33.3K 0.1% 150
2014
Q4 		$611K Sell
20,677
-211
-1% -$6.05K 0.1% 153
2014
Q3 		$586K Buy
20,888
+679
+3% +$19.1K 0.09% 155
2014
Q2 		$569K Sell
20,209
-494
-2% -$14.1K 0.09% 154
2014
Q1 		$631K Sell
20,703
-779
-4% -$23.2K 0.11% 145
2013
Q4 		$624K Sell
21,482
-210
-1% -$6.11K 0.1% 138
2013
Q3 		$591K Buy
21,692
+52
+0.2% +$1.42K 0.11% 135
2013
Q2 		$575K Buy
+21,640
New +$598K 0.11% 136

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lowe Brockenbrough & Co's PFE Position: Q1 2026 in Review

Lowe Brockenbrough & Co increased its Pfizer (PFE) stake by 14% in Q1 2026, buying an estimated $776K and bringing the position to 238,855 shares worth $6.71M. The position accounts for 0.33% of the portfolio, ranked #72.

Lowe Brockenbrough & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.73M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Lowe Brockenbrough & Co held 238,855 shares of Pfizer worth $6.71M as of Q1 2026.
  • Lowe Brockenbrough & Co bought 29,130 Pfizer shares in Q1 2026, an estimated $776K.
  • Pfizer made up 0.33% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #72 holding.
  • Lowe Brockenbrough & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Lowe Brockenbrough & Co's Pfizer position peaked at $9.73M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.